Interestingly, increased NK cells and CD8+ T cells tumor infiltration was reported using the DNA methyltransferase inhibitor (DNMTi), AzaC, through type I IFN signaling while reducing the tumor burden of the murine epithelial ovarian cancer model [75]. This evidence concerns the gene CD8A and neoplasm.